-
APEX-PS Maps RNA-Binding Proteins in Space and Time
2026-10-09
Qin and colleagues developed APEX-PS, a functional proximity-labeling strategy that combines compartment-specific peroxidase labeling with enrichment of crosslinked protein–RNA complexes. The approach identified SYNJ2BP as an outer mitochondrial membrane RNA-binding protein that helps preserve selected mitochondrial mRNAs during stress, supporting local translation and recovery of mitochondrial function.
-
BMS-345541 Hydrochloride: Reading IKK–RIPK1 Evidence
2026-10-09
BMS-345541 hydrochloride is a selective IKK inhibitor that can help separate NF-κB transcriptional signaling from RIPK1-associated cell-death phenotypes. This evidence-centered analysis explains what the compound can clarify, how the PPP1R3G–PP1γ study changes interpretation, and where conclusions remain model-dependent.
-
Olsalazine Sodium: Evidence Across Research Models
2026-10-08
Olsalazine Sodium is a mesalamine dimer investigated in inflammation, colorectal cancer, and xenobiotic transport research. This overview compares supplier-reported pharmacology with findings from a 2025 Aedes aegypti study, emphasizing evidence strength, applicability boundaries, and the limits of cross-model interpretation.
-
MG-132: Research Context, Findings, and Limitations
2026-10-08
MG-132, also known as Z-LLL-al, is a cell-permeable proteasome inhibitor used as a research perturbation tool in studies of protein quality control, apoptosis, cell-cycle regulation, and cellular stress. This overview separates catalog-level claims from primary evidence and explains how recent findings on UBR1 and UBR2 clarify both the value and the interpretive limits of proteasome inhibition.
-
Ionophore Toxicity in Animals: Molecular Insights
2026-10-07
The 2023 review by Ekinci, Chłodowska, and Olejnik connects clinical ionophore poisoning with cation dysregulation, impaired oxidative phosphorylation, and injury to myocardial and skeletal muscle cells. It also highlights species, age, dose, and tiamulin–ionophore interactions as important variables, while emphasizing that molecular mechanisms remain incompletely resolved.
-
S-Adenosylmethionine: Context Matters in Methylation
2026-10-07
S-Adenosylmethionine is more than a universal methyl donor: its biological meaning depends on substrate, enzyme, compartment, and evidence type. This article interprets a 2026 MaMT4 study to clarify how SAM research can connect biochemical selectivity with broader epigenetic and translational questions.
-
Fluorescence as a Bridge to Mucosal Vaccine Translation
2026-10-06
A mechanistic and translational analysis of how fluorescence can help researchers interpret intestinal targeting, sustained release, and mucosal immunity in a chick vaccine-adjuvant model—while distinguishing reported evidence from future research opportunities.
-
Busulfan: Evidence Across Senescence and Oogenesis
2026-10-06
Busulfan is a DNA alkylating agent used in research to study cellular stress, senescence, and germ-cell depletion. This overview separates supplier-described mechanisms from findings in a 2026 iScience pre-proof using dual-recombinase lineage tracing. The study reported no evidence of postnatal neo-oogenesis in mice under physiological conditions or after busulfan-induced ovarian injury, while its conclusions remain bounded by species, model, lineage-labeling, and pre-proof limitations.
-
Trifluoperazine 2HCl: Evidence Overview
2026-10-05
Trifluoperazine 2HCl is commonly described as a dopamine D2 receptor inhibitor and phenothiazine research probe. The strongest supplied recent evidence concerns phenothiazines as a class in macrophage-mediated antibacterial activity, with reported roles for reactive oxygen species and autophagy. However, the cited study does not establish that Trifluoperazine 2HCl itself produces the same effects or that they depend on D2 receptor signaling. Its most defensible current uses are hypothesis-driven research in neuropharmacology and comparative studies of phenothiazine-associated cellular mechanisms.
-
Tiamulin: Evidence, Mechanism, Scope and Limits
2026-10-04
A source-grounded overview of Tiamulin (Thiamutilin), covering its pleuromutilin mechanism, comparative metabolism evidence, veterinary relevance, anti-inflammatory claims, residue interpretation and the limits of translating supplier or laboratory findings into clinical conclusions.
-
Beyond Glycogen: Timing, Training, Translation
2026-10-03
Time-of-day biology is reshaping how translational researchers interpret exercise adaptation. This thought-leadership analysis connects recent mouse findings with glycogen measurement strategy, assay selection, and the limits of translating tissue-level metabolic readouts into clinical insight.
-
Tetrazolium (chloride) in Ischemic Tissue Research
2026-10-02
Tetrazolium (chloride), or Tetrazolium Red, converts dehydrogenase activity into a spatial map of tissue viability. This guide shows how to interpret TTC staining alongside molecular and histological readouts in ischemic injury research.
-
SB-505-124 hydrochloride Assay Guide
2026-10-01
A scenario-based guide to using SB-505-124 hydrochloride (SKU A3799) to separate TGF-β/activin signaling effects from nonspecific toxicity in viability, proliferation, fibrosis, and mechanobiology assays. It covers concentration selection, solvent controls, Smad2/3 interpretation, and practical vendor evaluation.
-
Leptin (116-130), amide, mouse: Assay Guide
2026-10-01
Build controlled metabolic and immunometabolic assays with a sequence-defined leptin fragment rather than treating it as interchangeable with full-length hormone. This guide connects dose-ranging, fresh-solution handling, and pathway controls to obesity, diabetes, and inflammation-focused workflows.
-
Ruxolitinib: From JAK1/2 Biology to Immune Insight
2026-09-30
Ruxolitinib (INCB018424) is more than a selective JAK1/2 kinase inhibitor. Its defined pharmacology can connect pathway suppression with progenitor-cell biology, myelofibrosis research, and high-dimensional immune remodeling in combination therapies.